Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Stephanie M, Gustavson"'
Autor:
Robert J. Mentz, M. Angelyn Bethel, Peter Merrill, Yuliya Lokhnygina, John B. Buse, Juliana C. Chan, João S. Felício, Shaun G. Goodman, Jasmine Choi, Stephanie M. Gustavson, Nayyar Iqbal, Renato D. Lopes, Aldo P. Maggioni, Peter Öhman, Neha J. Pagidipati, Neil R. Poulter, Ambady Ramachandran, Barry Reicher, Rury R. Holman, Adrian F. Hernandez
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 19 (2018)
Background In the EXSCEL (Exenatide Study of Cardiovascular Event Lowering), exenatide once‐weekly resulted in a nonsignificant reduction in major adverse cardiovascular events (MACEs) and a nominal 14% reduction in all‐cause mortality in 14 752
Externí odkaz:
https://doaj.org/article/0fea5ded97ad46fd8a2658707703a02e
Autor:
Stephanie M. Gustavson, Robert J. Mentz, Rishi A Patel, M. Angelyn Bethel, Peter Öhman, Nayyar Iqbal, Adrian F. Hernandez, Susanna R. Stevens, John B. Buse, Albert Lecube, Yuliya Lokhnygina, Guntram Schernthaner, Jasmine Choi, Rury R. Holman
Publikováno v:
Circulation. 141:1360-1370
Background: EXSCEL (Exenatide Study of Cardiovascular Event Lowering) assessed the impact of once-weekly exenatide 2 mg versus placebo in patients with type 2 diabetes mellitus, while aiming for glycemic equipoise. Consequently, greater drop-in of op
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::884e45ddac56a23e3aa9d47a01efdf2c
https://doi.org/10.1161/circulationaha.119.043353
https://doi.org/10.1161/circulationaha.119.043353
Autor:
Eric Wittbrodt, Kartman B, M A Bethel, Neha J. Pagidipati, Adrian F. Hernandez, Shelby D. Reed, Helen Dakin, Jose Leal, Robert J. Mentz, Rury R. Holman, Alastair Gray, Frauke Becker, Yanhong Li, Stephanie M. Gustavson
Publikováno v:
Diabetes Care
OBJECTIVE To compare medical resource use, costs, and health utilities for 14,752 patients with type 2 diabetes who were randomized to once-weekly exenatide (EQW) or placebo in addition to usual diabetes care in the Exenatide Study of Cardiovascular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d50c8eda562c31f044879e4864adf4ac
https://doi.org/10.2337/dc19-0950
https://doi.org/10.2337/dc19-0950
Autor:
Robert C. Penland, Marcus Thuresson, Robert J. Mentz, James Ruggles, C. David Sjöström, Adrian F. Hernandez, Srinivas Bachina, John B. Buse, Lindsay E. Clegg, Stephanie M. Gustavson, David W. Boulton, Hiddo J.L. Heerspink, Rury R. Holman
Publikováno v:
Cardiovascular Diabetology, Vol 18, Iss 1, Pp 1-12 (2019)
Cardiovascular Diabetology
Cardiovascular Diabetology, 18(1):138. BioMed Central Ltd.
Cardiovascular Diabetology
Cardiovascular Diabetology, 18(1):138. BioMed Central Ltd.
Background Sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1 RA) improve cardiovascular and renal outcomes in patients with type 2 diabetes through distinct mechanisms. However, evidence on clinic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b87451bb2dd9be2096ba11fff4cdb342
http://link.springer.com/article/10.1186/s12933-019-0942-x
http://link.springer.com/article/10.1186/s12933-019-0942-x
Autor:
Peter Öhman, Robert F. Gagel, Peter Merrill, John B. Buse, Adrian F. Hernandez, Vivian P. Thompson, Shelby D. Reed, Rishi A Patel, Yanhong Li, Stephanie M. Gustavson, Brian G. Katona, Rury R. Holman, Nayyar Iqbal, M. Angelyn Bethel, Sara Ahmadi
Publikováno v:
Diabetes Care
OBJECTIVE Increases in serum calcitonin, a tumor marker for medullary thyroid carcinoma (MTC), have been associated with glucagon-like peptide 1 receptor agonist use in some preclinical studies. We report calcitonin changes in exenatide-treated and p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::879f43610428489aa17714a4f963a0be
https://doi.org/10.2337/dc18-2028
https://doi.org/10.2337/dc18-2028
Autor:
Alastair Gray, Jose Leal, Helen Dakin, Shelby D. Reed, Stephanie M. Gustavson, Frauke Becker, Yanhong Li, Rury R. Holman, Eric Wittbrodt, Adrian F. Hernandez
Publikováno v:
Diabetes Research and Clinical Practice. 183:109152
Aims The Exenatide Study of Cardiovascular Event Lowering (EXSCEL) trial assessed once-weekly exenatide (EQW) vs. placebo, added to usual care in 14,752 patients with type 2 diabetes mellitus (Clinicaltrials.gov: NCT01144338). We assessed the lifetim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e24d4306c4eb418ea744ac4e6b75557a
https://doi.org/10.1016/j.diabres.2021.109152
https://doi.org/10.1016/j.diabres.2021.109152
Autor:
M. Angelyn Bethel, Adrian F. Hernandez, Ambady Ramachandran, Peter Öhman, John B. Buse, Stephanie M. Gustavson, Robert J. Mentz, Nayyar Iqbal, Juliana C.N. Chan, Aldo P. Maggioni, Neil Poulter, Bernard Zinman, Vivian P. Thompson, Rury R. Holman, Steven P. Marso, Neha J. Pagidipati
Publikováno v:
Am Heart J
Background EXSCEL is a randomized, double-blind, placebo-controlled trial examining the effect of exenatide once-weekly (EQW) versus placebo on time to the primary composite outcome (cardiovascular death, nonfatal myocardial infarction or nonfatal st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3db39c5b0d7a27ad6cd7775e76109a89
https://doi.org/10.1016/j.ahj.2017.02.005
https://doi.org/10.1016/j.ahj.2017.02.005
Autor:
Susanna R. Stevens, Adrian F. Hernandez, Aldo P. Maggioni, Eberhard Standl, M. Angelyn Bethel, Stephanie M. Gustavson, John B. Buse, Yuliya Lokhnygina, Rury R. Holman, Robert J. Mentz
Publikováno v:
Diabetes Care
OBJECTIVE We sought to confirm a bidirectional association between severe hypoglycemic events (SHEs) and cardiovascular (CV) event risk and to characterize individuals at dual risk. RESEARCH DESIGN AND METHODS In a post hoc analysis of 14,752 Exenati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67c451cc194b3239d4264086e17e9ba2
https://pubmed.ncbi.nlm.nih.gov/32079685
https://pubmed.ncbi.nlm.nih.gov/32079685
Autor:
Robert J, Mentz, Vivian P, Thompson, David, Aguilar, Jasmine, Choi, Stephanie M, Gustavson, Nayyar, Iqbal, Alice P, Kong, Peter, Öhman, Naveed, Sattar, Russell S, Scott, Yee Weng, Wong, Rury R, Holman, Adrian F, Hernandez
Publikováno v:
Circulation. 138(22)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::492ceab0b0ddc3f4453b6aaa94ffb183
https://pubmed.ncbi.nlm.nih.gov/30571356
https://pubmed.ncbi.nlm.nih.gov/30571356
Autor:
João S. Felício, Peter Merrill, M. Angelyn Bethel, Stephanie M. Gustavson, Ambady Ramachandran, Rury R. Holman, Jasmine Choi, Renato D. Lopes, Aldo P. Maggioni, Juliana C.N. Chan, Yuliya Lokhnygina, Neil R Poulter, Barry Reicher, Robert J. Mentz, Nayyar Iqbal, Neha J. Pagidipati, Adrian F. Hernandez, John B. Buse, Shaun G. Goodman, Peter Öhman
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background In the EXSCEL (Exenatide Study of Cardiovascular Event Lowering), exenatide once‐weekly resulted in a nonsignificant reduction in major adverse cardiovascular events ( MACEs ) and a nominal 14% reduction in all‐cause mortality in 14 75
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecd55d9417213f47709a7ecba80fb98f
http://hdl.handle.net/10044/1/65163
http://hdl.handle.net/10044/1/65163
